Ozzy Osbourne lived a life of great excess. And when he died this year at the age of 76, many were saddened but also surprised that it hadn't happened earlier.
“[He] had lived on the edge for such a long time, the fact he lived as long as he did was a miracle,” the rocker's close friend, Tom Morello said on a radio show.
It turns out the miracle was in his genes. You see, Osbourne had a rare genetic mutation that allowed him to metabolize alcohol and other substances much faster than normal. And this, say scientists, is what kept him alive despite decades of self-destructive behavior.
That interesting fact is one of many that can be found on an Instagram page called Science. The account has amassed a cool 1.7 million followers and it's not difficult to see why. Unlike many other facts pages, which purely share fast and fun tidbits, this one fleshes out each scientific fact and gives the context, explanation and source in a detailed caption.
Bored Panda has put together a list of the best posts from the page for you to scroll through instead of watching mindless shorts this weekend. So sit back, relax and let your brain thank you later. Don't forget to upvote your favorites.
#1
In a groundbreaking discovery blending nature with science, researchers found that bee venom can eliminate 100% of aggressive breast cancer cells in under 60 minutes!
The secret lies in melittin, a powerful molecule in honeybee venom that attacks and disables cancer cell membranes—while mostly sparing healthy cells. This remarkable finding opens new possibilities for targeted cancer therapies that could be both highly effective and less damaging than conventional treatments.
Though still in early stages, the research offers hope and reminds us that nature may hold answers to some of medicine’s toughest challenges. One day, the sting of a bee might symbolize not harm, but healing and resilience in the fight against cancer.
The secret lies in melittin, a powerful molecule in honeybee venom that attacks and disables cancer cell membranes—while mostly sparing healthy cells. This remarkable finding opens new possibilities for targeted cancer therapies that could be both highly effective and less damaging than conventional treatments.
Though still in early stages, the research offers hope and reminds us that nature may hold answers to some of medicine’s toughest challenges. One day, the sting of a bee might symbolize not harm, but healing and resilience in the fight against cancer.
Report
97points
#2
Fish pulled from water don't just "flop around"—they suffer up to 22 minutes of excruciating pain before losing consciousness.
Scientists at the Welfare Footprint Institute just published the first study to measure exactly how much fish suffer during air asphyxiation, the most common method used to k**l over a trillion fish annually. The results published are disturbing.
Rainbow trout experience between 2 and 25 minutes of moderate to excruciating pain when removed from water, with an average of 10 minutes of severe suffering. Within just five seconds of air exposure, fish show neurochemical responses identical to what humans experience during intense pain.
"When standardized by production output, this corresponds to an average of 24 minutes per kilogram, with over one hour of moderate to extreme pain per kilogram in some cases," lead researcher Cynthia Schuck-Paim explained.
Here's what actually happens when fish are pulled from water: their delicate gills collapse and stick together, preventing oxygen exchange. Carbon dioxide from respiration builds up rapidly, triggering the body's alarm system and causing frantic gasping. The rising CO2 levels acidify their blood and spinal fluid, eventually leading to unconsciousness.
Fish aren't just reacting on instinct—they possess nociceptors, the same specialized pain receptors found in humans. Brain imaging shows these signals activate areas responsible for conscious experience, not just reflexes. When researchers injected rainbow trout with acid, they stopped normal behavior until given morphine, proving they actually feel pain.
The ice slurry method commonly used in restaurants might be even worse, slowing metabolism and prolonging consciousness while fish slowly suffocate.
Electrical stunning could reduce this suffering dramatically. Researchers estimate it could save up to 20 hours of moderate to extreme pain per dollar spent on humane equipment.
This research forces an uncomfortable question about the 2.2 trillion fish k****d yearly: if they feel pain like we do, what does that mean for how we catch our dinner?
Scientists at the Welfare Footprint Institute just published the first study to measure exactly how much fish suffer during air asphyxiation, the most common method used to k**l over a trillion fish annually. The results published are disturbing.
Rainbow trout experience between 2 and 25 minutes of moderate to excruciating pain when removed from water, with an average of 10 minutes of severe suffering. Within just five seconds of air exposure, fish show neurochemical responses identical to what humans experience during intense pain.
"When standardized by production output, this corresponds to an average of 24 minutes per kilogram, with over one hour of moderate to extreme pain per kilogram in some cases," lead researcher Cynthia Schuck-Paim explained.
Here's what actually happens when fish are pulled from water: their delicate gills collapse and stick together, preventing oxygen exchange. Carbon dioxide from respiration builds up rapidly, triggering the body's alarm system and causing frantic gasping. The rising CO2 levels acidify their blood and spinal fluid, eventually leading to unconsciousness.
Fish aren't just reacting on instinct—they possess nociceptors, the same specialized pain receptors found in humans. Brain imaging shows these signals activate areas responsible for conscious experience, not just reflexes. When researchers injected rainbow trout with acid, they stopped normal behavior until given morphine, proving they actually feel pain.
The ice slurry method commonly used in restaurants might be even worse, slowing metabolism and prolonging consciousness while fish slowly suffocate.
Electrical stunning could reduce this suffering dramatically. Researchers estimate it could save up to 20 hours of moderate to extreme pain per dollar spent on humane equipment.
This research forces an uncomfortable question about the 2.2 trillion fish k****d yearly: if they feel pain like we do, what does that mean for how we catch our dinner?
Report
64points
#3
A single dose of magic mushrooms just beat years of daily antidepressants—and the effects lasted two full years.
Cancer patients with severe depression received just one 25-milligram dose of psilocybin in a clinical setting. Two years later, over half were still free from depression without taking any daily medication.
The results published in CANCER journal tracked 28 patients who underwent the treatment. After their single session, 50% achieved complete remission that persisted for 24 months. Compare that to traditional antidepressants, which require daily doses, often lose effectiveness over time, and need constant adjustments.
Even more remarkable: follow-up studies show 67% of patients remained depression-free five years after their single treatment session.
Dr. Manish Agrawal from Sunstone Therapies called it a "paradigm shift." Instead of managing symptoms with daily pills for years, patients experienced lasting brain changes from one carefully supervised session combined with psychological support.
The treatment isn't just swallowing a mushroom—it involves 11 hours of therapy before, during, and after the psilocybin experience. But the results speak for themselves: Johns Hopkins researchers found it worked four times better than conventional treatments.
This discovery challenges everything we know about treating depression. While millions struggle with medications that stop working or cause side effects, a single therapeutic session is providing years of relief. Scientists believe psilocybin creates permanent changes in brain function that persist long after the compound leaves the body, offering hope for the 280 million people worldwide living with depression.
Cancer patients with severe depression received just one 25-milligram dose of psilocybin in a clinical setting. Two years later, over half were still free from depression without taking any daily medication.
The results published in CANCER journal tracked 28 patients who underwent the treatment. After their single session, 50% achieved complete remission that persisted for 24 months. Compare that to traditional antidepressants, which require daily doses, often lose effectiveness over time, and need constant adjustments.
Even more remarkable: follow-up studies show 67% of patients remained depression-free five years after their single treatment session.
Dr. Manish Agrawal from Sunstone Therapies called it a "paradigm shift." Instead of managing symptoms with daily pills for years, patients experienced lasting brain changes from one carefully supervised session combined with psychological support.
The treatment isn't just swallowing a mushroom—it involves 11 hours of therapy before, during, and after the psilocybin experience. But the results speak for themselves: Johns Hopkins researchers found it worked four times better than conventional treatments.
This discovery challenges everything we know about treating depression. While millions struggle with medications that stop working or cause side effects, a single therapeutic session is providing years of relief. Scientists believe psilocybin creates permanent changes in brain function that persist long after the compound leaves the body, offering hope for the 280 million people worldwide living with depression.
Report
63points
#4
In the most desperate moment imaginable, a mother in rural Mexico did the impossible and survived.
On March 5, 2000, Inés Ramírez Pérez faced every pregnant woman's worst nightmare: 12 hours of agonizing labor with no medical help, no transportation, and the haunting memory of losing her previous baby to obstructed delivery. Living in a one-room cabin with no electricity, running water, or sanitation in the mountains of Oaxaca, the 40-year-old mother of six was completely alone when her husband went out.
With the nearest clinic over 50 miles away on treacherous mountain roads, Pérez decided to defy all medical logic. After consuming three glasses of hard liquor as anesthesia, she grabbed a 6-inch butchering knife and began c*****g through her own abdomen. Drawing on her experience slaughtering animals, she made three vertical incisions totaling 17 centimeters—much larger than a typical C-section—and reached inside her own uterus to pull out her baby boy.
The surgery took over an hour under a single dim bulb, during which she somehow avoided damaging vital organs by instinctively choosing a squatting position that positioned her uterus against the abdominal wall. After c*****g the umbilical cord with scissors, she wrapped her newborn son Orlando in clothes, sent her 6-year-old son for help, and lost consciousness.
When village health aide León Cruz arrived hours later, he found both mother and child alive—Pérez was alert and caring for her baby. Using an ordinary needle and cotton thread, he sewed up her massive wound before an 8-hour journey to the nearest hospital, where stunned doctors found no signs of infection, minimal bleeding, and perfect uterine recovery. Published in the International Journal of Gynecology & Obstetrics, her case represents the only documented successful self-inflicted C-section where both mother and child survived.
On March 5, 2000, Inés Ramírez Pérez faced every pregnant woman's worst nightmare: 12 hours of agonizing labor with no medical help, no transportation, and the haunting memory of losing her previous baby to obstructed delivery. Living in a one-room cabin with no electricity, running water, or sanitation in the mountains of Oaxaca, the 40-year-old mother of six was completely alone when her husband went out.
With the nearest clinic over 50 miles away on treacherous mountain roads, Pérez decided to defy all medical logic. After consuming three glasses of hard liquor as anesthesia, she grabbed a 6-inch butchering knife and began c*****g through her own abdomen. Drawing on her experience slaughtering animals, she made three vertical incisions totaling 17 centimeters—much larger than a typical C-section—and reached inside her own uterus to pull out her baby boy.
The surgery took over an hour under a single dim bulb, during which she somehow avoided damaging vital organs by instinctively choosing a squatting position that positioned her uterus against the abdominal wall. After c*****g the umbilical cord with scissors, she wrapped her newborn son Orlando in clothes, sent her 6-year-old son for help, and lost consciousness.
When village health aide León Cruz arrived hours later, he found both mother and child alive—Pérez was alert and caring for her baby. Using an ordinary needle and cotton thread, he sewed up her massive wound before an 8-hour journey to the nearest hospital, where stunned doctors found no signs of infection, minimal bleeding, and perfect uterine recovery. Published in the International Journal of Gynecology & Obstetrics, her case represents the only documented successful self-inflicted C-section where both mother and child survived.
Report
60points
#5
A week to a fuller head of hair? UCLA’s breakthrough cream makes it possible.
Hair loss may soon be history thanks to UCLA’s PP405 topical cream, which awakened dormant follicles in just seven days during early human trials. Unlike minoxidil or finasteride, PP405 works at the metabolic level—blocking a key protein that keeps hair follicle stem cells in hibernation. Once freed, these stem cells spring into action, producing robust, terminal hair instead of the fine fuzz most treatments yield.
In a Phase 2a study involving 78 men and women, participants applied the cream nightly for one week and began seeing new, thick strands emerge—and longer trials showed up to a 20% boost in hair density within eight weeks. This rapid regrowth surprised the UCLA team, who feared PP405 might damage follicles but instead confirmed its safety and efficacy.
Backed by Google Ventures and shepherded through UCLA’s Technology Transfer Group, Pelage Pharmaceuticals has raised over $16 million to fund larger trials and pursue FDA clearance. If all goes smoothly, PP405 could hit the market by 2027, offering a genuine cure for pattern baldness and post-chemotherapy hair loss.
Hair loss may soon be history thanks to UCLA’s PP405 topical cream, which awakened dormant follicles in just seven days during early human trials. Unlike minoxidil or finasteride, PP405 works at the metabolic level—blocking a key protein that keeps hair follicle stem cells in hibernation. Once freed, these stem cells spring into action, producing robust, terminal hair instead of the fine fuzz most treatments yield.
In a Phase 2a study involving 78 men and women, participants applied the cream nightly for one week and began seeing new, thick strands emerge—and longer trials showed up to a 20% boost in hair density within eight weeks. This rapid regrowth surprised the UCLA team, who feared PP405 might damage follicles but instead confirmed its safety and efficacy.
Backed by Google Ventures and shepherded through UCLA’s Technology Transfer Group, Pelage Pharmaceuticals has raised over $16 million to fund larger trials and pursue FDA clearance. If all goes smoothly, PP405 could hit the market by 2027, offering a genuine cure for pattern baldness and post-chemotherapy hair loss.
Report
55points
#6
Mexico City is rewriting its skyline—literally—with a bold experiment in urban greening known as Vía Verde. Spearheaded by architect Fernando Ortiz Monasterio and his firm Verde Vertical, the project transforms over 1,000 concrete pillars of the city’s Anillo Periférico highway into living, breathing vertical gardens.
These smart green columns span more than 60,000 square meters and are irrigated using rainwater and greywater through an automated, sensor-driven hydroponic system. The plants—selected for their resilience and low water needs—grow not in soil, but in specially designed textiles made from recycled materials.
Vía Verde’s goals are as ambitious as its design: filter 27,000 tons of toxic gas annually, trap 5,000 kg of heavy metals, and generate enough oxygen for 25,000 people. The gardens also reduce traffic noise and urban heat, while creating jobs for locals, including inmates performing community service.
Each column features its own real-time monitoring sensors to track light, temperature, and hydration, ensuring plants receive precise care without waste. The modular structure allows rapid installation and minimal disruption to traffic, which has been critical to public support.
But the project has critics. Some urban activists argue it’s aesthetic greenwashing—beautifying a car-centric system rather than investing in public transport or planting trees. Others question the air-purifying claims, noting many of the plant species used aren’t ideal for phytoremediation. Still, with international expansion underway and WEF recognition secured, Vía Verde is becoming a global model for vertical greening.
Its long-term goal? To scale from pillars to walls, roofs, and tunnels—covering 10 million square meters by 2030. Even then, Ortiz admits, it would only meet a fraction of WHO’s recommended green space per capita.
These smart green columns span more than 60,000 square meters and are irrigated using rainwater and greywater through an automated, sensor-driven hydroponic system. The plants—selected for their resilience and low water needs—grow not in soil, but in specially designed textiles made from recycled materials.
Vía Verde’s goals are as ambitious as its design: filter 27,000 tons of toxic gas annually, trap 5,000 kg of heavy metals, and generate enough oxygen for 25,000 people. The gardens also reduce traffic noise and urban heat, while creating jobs for locals, including inmates performing community service.
Each column features its own real-time monitoring sensors to track light, temperature, and hydration, ensuring plants receive precise care without waste. The modular structure allows rapid installation and minimal disruption to traffic, which has been critical to public support.
But the project has critics. Some urban activists argue it’s aesthetic greenwashing—beautifying a car-centric system rather than investing in public transport or planting trees. Others question the air-purifying claims, noting many of the plant species used aren’t ideal for phytoremediation. Still, with international expansion underway and WEF recognition secured, Vía Verde is becoming a global model for vertical greening.
Its long-term goal? To scale from pillars to walls, roofs, and tunnels—covering 10 million square meters by 2030. Even then, Ortiz admits, it would only meet a fraction of WHO’s recommended green space per capita.
Report
54points
#7
A sweeping six‑month experiment involving nearly 3,000 employees across 141 organizations in Australia, Canada, Ireland, New Zealand, the U.K., and the U.S. has revealed profound impacts of c*****g the standard workweek from five days to four—without c*****g pay. 🧪 Employees reported dramatically lower burnout, better mental health, higher job satisfaction, and even improvements in physical health, with many noting stronger focus, sharper decision-making, and a revived sense of purpose in their work.
Companies in the program, supported by the nonprofit 4 Day Week Global, were coached to streamline meetings and workflows before the change. Weekly hours dropped from about 39 to 34 on average, and those who reduced hours by eight or more per week experienced the strongest gains. Workers slept better, felt less fatigue, and reported a sharper sense of effectiveness at their jobs, which often led to richer collaboration and more innovative thinking.
Far from cramming five days of tasks into four, participants often described feeling calmer and more focused, with a sense that their time was truly valued. Managers saw especially strong improvements in their own well‑being, reporting more balance, clarity, and confidence in leading their teams. A year later, surveys still showed benefits—proof this wasn’t just a short‑term morale boost but a sustainable transformation in workplace culture and employee health.
Concerns about lost productivity didn’t materialize: over 90% of participating companies chose to keep the schedule after the trial, citing stronger engagement and reduced turnover. Researchers note that voluntary participation and self‑reporting may skew results, but the consistency across countries and industries is striking, suggesting a global appetite for a better balance.
Source: s41562-025-02259-6
Companies in the program, supported by the nonprofit 4 Day Week Global, were coached to streamline meetings and workflows before the change. Weekly hours dropped from about 39 to 34 on average, and those who reduced hours by eight or more per week experienced the strongest gains. Workers slept better, felt less fatigue, and reported a sharper sense of effectiveness at their jobs, which often led to richer collaboration and more innovative thinking.
Far from cramming five days of tasks into four, participants often described feeling calmer and more focused, with a sense that their time was truly valued. Managers saw especially strong improvements in their own well‑being, reporting more balance, clarity, and confidence in leading their teams. A year later, surveys still showed benefits—proof this wasn’t just a short‑term morale boost but a sustainable transformation in workplace culture and employee health.
Concerns about lost productivity didn’t materialize: over 90% of participating companies chose to keep the schedule after the trial, citing stronger engagement and reduced turnover. Researchers note that voluntary participation and self‑reporting may skew results, but the consistency across countries and industries is striking, suggesting a global appetite for a better balance.
Source: s41562-025-02259-6
Report
54points
#8
Columbia scientists just c*****d the code on melting belly fat exactly where you want it—without destroying a single fat cell.
University researchers Li Qiang and Kam Leong discovered that positively charged nanomaterials can navigate through fat tissue like a GPS system, targeting specific problem areas with surgical precision. Their breakthrough compound, PAMAM generation 3 (P-G3), works by exploiting the negatively charged highways that naturally exist within fat deposits.
But here's what stunned the research team: instead of destroying fat cells like liposuction, P-G3 "rejuvenates" them back to a healthier state. The injection shuts off the unhealthy lipid storage program in enlarged fat cells, forcing them to behave like the small, metabolically active fat cells found in newborns and elite athletes. As Qiang explained, "With P-G3, fat cells can still be fat cells, but they can't grow up".
The results were remarkable in both animal studies and human fat biopsies. Mice injected with P-G3 not only lost weight in targeted areas but showed improved fat metabolism throughout their bodies. The treatment works by uncoupling lipid storage from the essential housekeeping functions of fat cells, creating more of the beneficial smaller fat cells while preventing the formation of problematic enlarged ones.
What makes this revolutionary is the precision: like Botox for fat, P-G3 can be injected into specific subcutaneous fat deposits, allowing doctors to sculpt bodies without surgery or systemic side effects. The researchers, who have patents pending, are now engineering P-G3 derivatives and developing it as a platform for delivering other fat-targeting therapies. This represents the first time scientists have successfully used cationic charge to treat obesity—opening an entirely new frontier in safe, targeted fat reduction.
University researchers Li Qiang and Kam Leong discovered that positively charged nanomaterials can navigate through fat tissue like a GPS system, targeting specific problem areas with surgical precision. Their breakthrough compound, PAMAM generation 3 (P-G3), works by exploiting the negatively charged highways that naturally exist within fat deposits.
But here's what stunned the research team: instead of destroying fat cells like liposuction, P-G3 "rejuvenates" them back to a healthier state. The injection shuts off the unhealthy lipid storage program in enlarged fat cells, forcing them to behave like the small, metabolically active fat cells found in newborns and elite athletes. As Qiang explained, "With P-G3, fat cells can still be fat cells, but they can't grow up".
The results were remarkable in both animal studies and human fat biopsies. Mice injected with P-G3 not only lost weight in targeted areas but showed improved fat metabolism throughout their bodies. The treatment works by uncoupling lipid storage from the essential housekeeping functions of fat cells, creating more of the beneficial smaller fat cells while preventing the formation of problematic enlarged ones.
What makes this revolutionary is the precision: like Botox for fat, P-G3 can be injected into specific subcutaneous fat deposits, allowing doctors to sculpt bodies without surgery or systemic side effects. The researchers, who have patents pending, are now engineering P-G3 derivatives and developing it as a platform for delivering other fat-targeting therapies. This represents the first time scientists have successfully used cationic charge to treat obesity—opening an entirely new frontier in safe, targeted fat reduction.
Report
52points
#9
The Prince of Darkness became the King of Genetics—and changed addiction science forever.
In 2010, Ozzy Osbourne made history beyond heavy metal: he became one of the first rock stars to have his entire genome sequenced. After surviving 40 years of legendary excess, scientists at Knome Inc. had one burning question—how was he still alive at the time?
The answer was in his DNA. Researchers discovered that Ozzy carries several hundred thousand genetic variants never seen before in humans, making him what geneticist Nathaniel Pearson called "indeed a genetic mutant". Most shocking was his ADH4 gene mutation—a never-before-seen variant that allows him to metabolize alcohol significantly faster than normal people.
But this genetic superpower came with a dark side. The same mutation made Ozzy six times more likely to develop alcohol addiction than the average person, providing the first concrete evidence of how genetics predispose individuals to substance dependency. His DNA also revealed variants in dopamine processing genes, o****d receptors, and methamphetamine metabolism, essentially a genetic blueprint for addiction.
The research, presented at TEDMED 2010, revolutionized our understanding of addiction science. Scientists discovered that Ozzy's survival wasn't just luck—his COMT gene variants** created a "warrior/worrier" combination affecting his brain chemistry, while CLTCL1 mutations rewired his neural communication systems entirely.
Perhaps most ironic: despite surviving decades of every conceivable substance, researchers found that **caffeine was his genetic kryptonite**[2]—his DNA showed he metabolizes coffee extremely slowly, making him unusually sensitive to its effects.
In 2010, Ozzy Osbourne made history beyond heavy metal: he became one of the first rock stars to have his entire genome sequenced. After surviving 40 years of legendary excess, scientists at Knome Inc. had one burning question—how was he still alive at the time?
The answer was in his DNA. Researchers discovered that Ozzy carries several hundred thousand genetic variants never seen before in humans, making him what geneticist Nathaniel Pearson called "indeed a genetic mutant". Most shocking was his ADH4 gene mutation—a never-before-seen variant that allows him to metabolize alcohol significantly faster than normal people.
But this genetic superpower came with a dark side. The same mutation made Ozzy six times more likely to develop alcohol addiction than the average person, providing the first concrete evidence of how genetics predispose individuals to substance dependency. His DNA also revealed variants in dopamine processing genes, o****d receptors, and methamphetamine metabolism, essentially a genetic blueprint for addiction.
The research, presented at TEDMED 2010, revolutionized our understanding of addiction science. Scientists discovered that Ozzy's survival wasn't just luck—his COMT gene variants** created a "warrior/worrier" combination affecting his brain chemistry, while CLTCL1 mutations rewired his neural communication systems entirely.
Perhaps most ironic: despite surviving decades of every conceivable substance, researchers found that **caffeine was his genetic kryptonite**[2]—his DNA showed he metabolizes coffee extremely slowly, making him unusually sensitive to its effects.
Report
51points
#10
Scientists at Emory University and Baylor College of Medicine just published the first experimental proof that psilocybin, the psychedelic compound in magic mushrooms, can dramatically extend life at the cellular level. Human lung and skin cells treated with psilocin—psilocybin's active ingredient—lived up to 57% longer than untreated cells.
But the real shock came from the mouse studies. Researchers gave 19-month-old mice (equivalent to 60-65 human years) monthly psilocybin doses for 10 months. The results exceeded expectations: 80% of treated mice survived compared to just 50% of untreated controls.
Even more remarkable, these elderly mice began showing signs of youth within three months. Their white fur turned brown again, bald spots regrew hair, and they became more physically active. It was like watching time reverse itself.
The mechanism centers on psilocybin's interaction with serotonin receptors found throughout the body—not just the brain. The compound preserves telomere length (the protective caps on chromosomes that shorten with age), boosts SIRT1 proteins associated with longevity, and reduces cellular damage from oxidative stress278.
Dr. Louise Hecker, the study's senior author, admitted being "floored by the data"—everything they tested for cellular rejuvenation simply worked. Published in Nature's prestigious npj Aging journal, this research opens entirely new possibilities for psychedelics beyond mental health treatment.
While more human trials are needed, the anti-aging industry's $500+ million market may have just found its most promising breakthrough—hidden in fungi that have been growing under our feet for millennia.
But the real shock came from the mouse studies. Researchers gave 19-month-old mice (equivalent to 60-65 human years) monthly psilocybin doses for 10 months. The results exceeded expectations: 80% of treated mice survived compared to just 50% of untreated controls.
Even more remarkable, these elderly mice began showing signs of youth within three months. Their white fur turned brown again, bald spots regrew hair, and they became more physically active. It was like watching time reverse itself.
The mechanism centers on psilocybin's interaction with serotonin receptors found throughout the body—not just the brain. The compound preserves telomere length (the protective caps on chromosomes that shorten with age), boosts SIRT1 proteins associated with longevity, and reduces cellular damage from oxidative stress278.
Dr. Louise Hecker, the study's senior author, admitted being "floored by the data"—everything they tested for cellular rejuvenation simply worked. Published in Nature's prestigious npj Aging journal, this research opens entirely new possibilities for psychedelics beyond mental health treatment.
While more human trials are needed, the anti-aging industry's $500+ million market may have just found its most promising breakthrough—hidden in fungi that have been growing under our feet for millennia.
Report
49points
#11
Surgeons just broke every rule in the medical playbook—and saved a 19-year-old's life by going through her eye socket.
When Karla Flores started experiencing double vision while learning to drive, she never imagined doctors would find a rare malignant tumor strangling her spinal cord. The chordoma—a bone cancer so rare only 300 cases are diagnosed in the U.S. each year—had wrapped around her spine just below the skull base, making traditional surgery extremely dangerous.
University of Maryland's Dr. Mohamed Labib faced an impossible choice: risk paralyzing the teenager by approaching from behind, or pioneer a completely untested surgical route. His solution? Go through her eye socket—a path never before used for spinal tumors.
The 19-hour procedure involved carefully displacing Flores' eyeball by millimeters, removing part of her eye socket and cheekbone, then threading an endoscope down to reach her spine. As Labib described it: "It was a straight shot" that avoided critical blood vessels, nerves controlling speech and swallowing, and the spinal cord itself.
But the real shock came when doctors discovered Flores actually had two separate chordomas—one around her brainstem requiring additional surgeries through her skull and nose. The multi-tumor nightmare that should have been a death sentence became a medical breakthrough.
The transorbital approach left no visible scars and preserved all major functions. After reconstructing her eye socket with titanium plates and hip bone grafts, plus proton radiation therapy, Flores is now completely cancer-free.
Her case has opened an entirely new surgical pathway that could help thousands of patients with previously inoperable skull base tumors.
Source: University of Maryland
When Karla Flores started experiencing double vision while learning to drive, she never imagined doctors would find a rare malignant tumor strangling her spinal cord. The chordoma—a bone cancer so rare only 300 cases are diagnosed in the U.S. each year—had wrapped around her spine just below the skull base, making traditional surgery extremely dangerous.
University of Maryland's Dr. Mohamed Labib faced an impossible choice: risk paralyzing the teenager by approaching from behind, or pioneer a completely untested surgical route. His solution? Go through her eye socket—a path never before used for spinal tumors.
The 19-hour procedure involved carefully displacing Flores' eyeball by millimeters, removing part of her eye socket and cheekbone, then threading an endoscope down to reach her spine. As Labib described it: "It was a straight shot" that avoided critical blood vessels, nerves controlling speech and swallowing, and the spinal cord itself.
But the real shock came when doctors discovered Flores actually had two separate chordomas—one around her brainstem requiring additional surgeries through her skull and nose. The multi-tumor nightmare that should have been a death sentence became a medical breakthrough.
The transorbital approach left no visible scars and preserved all major functions. After reconstructing her eye socket with titanium plates and hip bone grafts, plus proton radiation therapy, Flores is now completely cancer-free.
Her case has opened an entirely new surgical pathway that could help thousands of patients with previously inoperable skull base tumors.
Source: University of Maryland
Report
46points
#12
Japanese scientists just did the impossible—they used CRISPR to remove the extra chromosome that causes Down syndrome and restored normal cell function.
For the first time, researchers have successfully eliminated the root cause of Down syndrome at the cellular level. Dr. Ryotaro Hashizume's team at Mie University developed a precision gene-editing technique that targets and removes only the extra copy of chromosome 21, leaving the normal pair intact.
Down syndrome affects 1 in 700 births worldwide and occurs when cells have three copies of chromosome 21 instead of two. This extra genetic material disrupts normal development, causing intellectual disabilities, distinctive physical features, and serious health complications including heart defects and early-onset Alzheimer's.
The breakthrough uses "allele-specific editing"—a technique that trains CRISPR-Cas9 to recognize sequences unique to just the extra chromosome. When the molecular scissors make precise cuts in the unwanted chromosome, it becomes unstable and gets naturally discarded when cells divide.
The technique achieved up to 30.6% success rates in removing the extra chromosome, and treated cells showed completely normalized gene expression, protein production, and survival rates. Even more remarkable—it worked in both stem cells and mature skin cells taken directly from people with Down syndrome.
While clinical applications remain years away, the research opens unprecedented possibilities for preventing the complications that typically shorten lives of people with Down syndrome.
For the first time, researchers have successfully eliminated the root cause of Down syndrome at the cellular level. Dr. Ryotaro Hashizume's team at Mie University developed a precision gene-editing technique that targets and removes only the extra copy of chromosome 21, leaving the normal pair intact.
Down syndrome affects 1 in 700 births worldwide and occurs when cells have three copies of chromosome 21 instead of two. This extra genetic material disrupts normal development, causing intellectual disabilities, distinctive physical features, and serious health complications including heart defects and early-onset Alzheimer's.
The breakthrough uses "allele-specific editing"—a technique that trains CRISPR-Cas9 to recognize sequences unique to just the extra chromosome. When the molecular scissors make precise cuts in the unwanted chromosome, it becomes unstable and gets naturally discarded when cells divide.
The technique achieved up to 30.6% success rates in removing the extra chromosome, and treated cells showed completely normalized gene expression, protein production, and survival rates. Even more remarkable—it worked in both stem cells and mature skin cells taken directly from people with Down syndrome.
While clinical applications remain years away, the research opens unprecedented possibilities for preventing the complications that typically shorten lives of people with Down syndrome.
Report
44points
#13
The NHS has become the first health system in Europe to roll out a revolutionary cancer injection that treats 15 types of cancer in just 3-5 minutes.
The injectable form of nivolumab, an immunotherapy drug previously administered through IV drips, can now be delivered as a quick under-the-skin injection. This breakthrough affects treatment for lung, kidney, bladder, skin, bowel, esophageal, and head and neck cancers, among others.
Following approval from the UK's Medicines and Healthcare products Regulatory Agency, approximately 1,200 patients per month in England will benefit from this faster delivery method. The injection reduces treatment time from 30-60 minutes to just minutes, while maintaining the same therapeutic effectiveness.
Clinical trials demonstrated that patients strongly preferred the subcutaneous injection over traditional IV infusions. The time savings are substantial—NHS teams will save around 1,000 hours of treatment time monthly, equivalent to more than one full year annually.
Nivolumab works as an immunotherapy by blocking the PD-1 protein on immune system T-cells, preventing cancer cells from switching off the body's natural defense mechanisms. This allows the immune system to better detect and destroy cancer cells.
About two in five patients currently receiving IV nivolumab should be eligible for the new injection format. The faster treatment comes at no additional cost to the NHS due to existing agreements with manufacturer Bristol Myers Squibb.
The development addresses a critical need in cancer care, where patients previously spent hours in hospital treatment chairs every two to four weeks. The injection can be administered in outpatient settings, dramatically reducing the burden on both patients and healthcare systems.
The injectable form of nivolumab, an immunotherapy drug previously administered through IV drips, can now be delivered as a quick under-the-skin injection. This breakthrough affects treatment for lung, kidney, bladder, skin, bowel, esophageal, and head and neck cancers, among others.
Following approval from the UK's Medicines and Healthcare products Regulatory Agency, approximately 1,200 patients per month in England will benefit from this faster delivery method. The injection reduces treatment time from 30-60 minutes to just minutes, while maintaining the same therapeutic effectiveness.
Clinical trials demonstrated that patients strongly preferred the subcutaneous injection over traditional IV infusions. The time savings are substantial—NHS teams will save around 1,000 hours of treatment time monthly, equivalent to more than one full year annually.
Nivolumab works as an immunotherapy by blocking the PD-1 protein on immune system T-cells, preventing cancer cells from switching off the body's natural defense mechanisms. This allows the immune system to better detect and destroy cancer cells.
About two in five patients currently receiving IV nivolumab should be eligible for the new injection format. The faster treatment comes at no additional cost to the NHS due to existing agreements with manufacturer Bristol Myers Squibb.
The development addresses a critical need in cancer care, where patients previously spent hours in hospital treatment chairs every two to four weeks. The injection can be administered in outpatient settings, dramatically reducing the burden on both patients and healthcare systems.
Report
42points
#14
Harvard scientists just discovered that Alzheimer's might be caused by your brain running out of a mineral you never knew it needed—and they can reverse it in mice.
After a decade-long investigation published in Nature, researchers at Harvard Medical School have identified lithium deficiency as one of the earliest triggers of Alzheimer's disease. For the first time, scientists proved that lithium occurs naturally in human brains at biologically meaningful levels, functioning like other essential nutrients such as vitamin C or iron. Lead researcher Dr. Bruce Yankner explains this groundbreaking finding: "Lithium turns out to be like other nutrients we get from the environment—it's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful."
But here's where the discovery gets revolutionary: the study reveals that amyloid plaques don't just damage the brain—they actively steal lithium by binding to and sequestering this critical mineral. Through analysis of hundreds of donated brain tissue samples, researchers found that people with Alzheimer's and mild cognitive impairment had significantly reduced lithium levels compared to healthy individuals, with the deficiency appearing even at the earliest stages of memory loss.
The breakthrough came when scientists developed lithium orotate, a specialized compound that can evade capture by amyloid plaques. When given to mice with Alzheimer's-like symptoms, this treatment achieved something unprecedented: reversing memory loss and reducing amyloid plaque burden by 70%. In some advanced cases, the compound almost completely eliminated amyloid beta plaques. Most remarkably, the effective dose was one-thousandth of what's typically prescribed for bipolar disorder, with mice showing no toxicity even after lifelong treatment.
Unlike current Alzheimer's d***s that merely slow decline, lithium orotate actually restored memory function even in older mice with advanced disease. While clinical trials in humans are still needed, this research suggests we may finally have found the missing piece in the Alzheimer's puzzle.
After a decade-long investigation published in Nature, researchers at Harvard Medical School have identified lithium deficiency as one of the earliest triggers of Alzheimer's disease. For the first time, scientists proved that lithium occurs naturally in human brains at biologically meaningful levels, functioning like other essential nutrients such as vitamin C or iron. Lead researcher Dr. Bruce Yankner explains this groundbreaking finding: "Lithium turns out to be like other nutrients we get from the environment—it's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful."
But here's where the discovery gets revolutionary: the study reveals that amyloid plaques don't just damage the brain—they actively steal lithium by binding to and sequestering this critical mineral. Through analysis of hundreds of donated brain tissue samples, researchers found that people with Alzheimer's and mild cognitive impairment had significantly reduced lithium levels compared to healthy individuals, with the deficiency appearing even at the earliest stages of memory loss.
The breakthrough came when scientists developed lithium orotate, a specialized compound that can evade capture by amyloid plaques. When given to mice with Alzheimer's-like symptoms, this treatment achieved something unprecedented: reversing memory loss and reducing amyloid plaque burden by 70%. In some advanced cases, the compound almost completely eliminated amyloid beta plaques. Most remarkably, the effective dose was one-thousandth of what's typically prescribed for bipolar disorder, with mice showing no toxicity even after lifelong treatment.
Unlike current Alzheimer's d***s that merely slow decline, lithium orotate actually restored memory function even in older mice with advanced disease. While clinical trials in humans are still needed, this research suggests we may finally have found the missing piece in the Alzheimer's puzzle.
Report
41points
#15
Swiss researchers have pioneered an astonishing material: wood that glows softly in the dark without electricity. Drawing inspiration from a natural phenomenon called foxfire—where certain fungi illuminate decaying trees—the team at Empa’s Cellulose & Wood Materials lab combined balsa wood with the ringless honey fungus, Desarmillaria tabescens. After incubating the wood in a carefully controlled, humid environment for three months, the fungal threads permeate the fibers, breaking down lignin but leaving the cellulose intact. This transformation preserves the wood’s strength while embedding it with a latent ability to emit a ghostly green light.
When exposed to oxygen, the luciferase enzyme inside the fungus triggers a chemical reaction, producing a steady glow measured at around 560 nanometers in wavelength. Early tests show that the light lasts for about ten days, and while it’s not bright enough to replace modern lamps yet, the potential is groundbreaking. Imagine park benches, wooden railings, or even home furniture that light your path without wires or batteries. Researchers are already working to increase the intensity and lifespan of the glow, envisioning sustainable lighting solutions that could dramatically reduce energy consumption.
The concept revives a wisdom once known to ancient thinkers like Aristotle, who described luminous wood centuries ago. Now, through modern science, a fusion of biology and materials engineering could reshape how we design our cities and homes. By merging living fungal systems with nonliving materials, this biohybrid technology opens the door to energy-efficient, environmentally conscious illumination. It’s a bold step that blends history, innovation, and sustainability—lighting the way toward a greener future. ✨🌱
Source: 10.1002/advs.202403215
When exposed to oxygen, the luciferase enzyme inside the fungus triggers a chemical reaction, producing a steady glow measured at around 560 nanometers in wavelength. Early tests show that the light lasts for about ten days, and while it’s not bright enough to replace modern lamps yet, the potential is groundbreaking. Imagine park benches, wooden railings, or even home furniture that light your path without wires or batteries. Researchers are already working to increase the intensity and lifespan of the glow, envisioning sustainable lighting solutions that could dramatically reduce energy consumption.
The concept revives a wisdom once known to ancient thinkers like Aristotle, who described luminous wood centuries ago. Now, through modern science, a fusion of biology and materials engineering could reshape how we design our cities and homes. By merging living fungal systems with nonliving materials, this biohybrid technology opens the door to energy-efficient, environmentally conscious illumination. It’s a bold step that blends history, innovation, and sustainability—lighting the way toward a greener future. ✨🌱
Source: 10.1002/advs.202403215
Report
40points
#16
Scientists just proved what millions of internet users already suspected—watching dog videos actually works as digital therapy.
A groundbreaking study from the University of British Columbia tested over 1,000 people and found that just five minutes of watching therapy dogs on screen delivered stress relief comparable to real, in-person animal interactions. The research represents the largest scientific validation yet of something social media users have been doing instinctively for years.
Dr. John-Tyler Binfet, who leads UBC's Building Academic Retention through K9s program, was amazed by the results. "Our findings demonstrate that even with a virtual session, there was a significant reduction in stress among both the student population and the general public, regardless of age."
A separate University of Leeds study using physiological measurements found that watching 30-minute animal videos—including dogs—produced measurable health improvements. Participants' blood pressure dropped from an average of 136/88 to 115/71, heart rates decreased by 6.5%, and anxiety levels fell by 35%.
Even more surprising: active dog videos showing dogs playing worked better than tranquil videos of resting dogs. The playful footage not only reduced stress and anxiety but also boosted alertness, attention, and positive emotions more effectively than peaceful nature scenes.
The findings suggest that our collective obsession with dog videos isn't just mindless scrolling—it's inadvertent self-care backed by solid science.
A groundbreaking study from the University of British Columbia tested over 1,000 people and found that just five minutes of watching therapy dogs on screen delivered stress relief comparable to real, in-person animal interactions. The research represents the largest scientific validation yet of something social media users have been doing instinctively for years.
Dr. John-Tyler Binfet, who leads UBC's Building Academic Retention through K9s program, was amazed by the results. "Our findings demonstrate that even with a virtual session, there was a significant reduction in stress among both the student population and the general public, regardless of age."
A separate University of Leeds study using physiological measurements found that watching 30-minute animal videos—including dogs—produced measurable health improvements. Participants' blood pressure dropped from an average of 136/88 to 115/71, heart rates decreased by 6.5%, and anxiety levels fell by 35%.
Even more surprising: active dog videos showing dogs playing worked better than tranquil videos of resting dogs. The playful footage not only reduced stress and anxiety but also boosted alertness, attention, and positive emotions more effectively than peaceful nature scenes.
The findings suggest that our collective obsession with dog videos isn't just mindless scrolling—it's inadvertent self-care backed by solid science.
Report
39points
#17
Axolotl mucus contains peptides that specifically k**l breast cancer cells and attack antibiotic-resistant bacteria without harming healthy tissue.
A study published in PLOS ONE examined antimicrobial peptides found in the skin mucus of laboratory axolotls. Researchers at Hannover Medical School discovered that these compounds not only combat multi-resistant bacteria but also trigger programmed cell death in cancer cells.
Dr. Sarah Strauß and her team obtained mucus by gently massaging axolotls with sterile gloves, then extracted and synthesized 22 peptide candidates from thousands of compounds. Four of these peptides proved effective against MRSA (methicillin-resistant Staphylococcus aureus), with some performing better than vancomycin, a reserve antibiotic used when conventional treatments fail.
Three of the four anti-MRSA peptides also demonstrated anti-cancer properties. In cell culture experiments, these compounds triggered programmed cell death in breast cancer cells while leaving healthy breast tissue unaffected.
The peptides work through their unique chemical structure, which contains positively charged amino acids and water-repelling components. This allows them to bind to bacterial cell walls, creating holes or penetrating cells to cause death. The same mechanism appears to selectively target cancer cells.
MRSA causes approximately 20,000 infections annually in the United States and represents a growing threat as bacteria develop resistance to existing antibiotics. The research suggests that antimicrobial peptides from axolotl mucus could serve as alternatives to conventional antibiotics, with the added benefit that pathogens find it more difficult to develop resistance against them.
A study published in PLOS ONE examined antimicrobial peptides found in the skin mucus of laboratory axolotls. Researchers at Hannover Medical School discovered that these compounds not only combat multi-resistant bacteria but also trigger programmed cell death in cancer cells.
Dr. Sarah Strauß and her team obtained mucus by gently massaging axolotls with sterile gloves, then extracted and synthesized 22 peptide candidates from thousands of compounds. Four of these peptides proved effective against MRSA (methicillin-resistant Staphylococcus aureus), with some performing better than vancomycin, a reserve antibiotic used when conventional treatments fail.
Three of the four anti-MRSA peptides also demonstrated anti-cancer properties. In cell culture experiments, these compounds triggered programmed cell death in breast cancer cells while leaving healthy breast tissue unaffected.
The peptides work through their unique chemical structure, which contains positively charged amino acids and water-repelling components. This allows them to bind to bacterial cell walls, creating holes or penetrating cells to cause death. The same mechanism appears to selectively target cancer cells.
MRSA causes approximately 20,000 infections annually in the United States and represents a growing threat as bacteria develop resistance to existing antibiotics. The research suggests that antimicrobial peptides from axolotl mucus could serve as alternatives to conventional antibiotics, with the added benefit that pathogens find it more difficult to develop resistance against them.
Report
38points
#18
The great eared nightjar is one of nature’s most striking birds, renowned for its almost mythical appearance. Found across the forests of South and Southeast Asia—stretching from Sri Lanka and India to the Philippines and Vietnam—this species captivates observers with its dramatic features and extraordinary camouflage. Its mottled plumage of browns, grays, and blacks melts into the forest floor like living shadow, and its long, lynx‑like ear tufts and piercing eyes give it an eerie, dragon‑like presence few forget once seen.
By day, the nightjar vanishes into the undergrowth, perfectly still, almost impossible to spot even a few feet away. But when twilight falls, it stirs to life, gliding effortlessly through the dark like a phantom. With a wide, gaping mouth and ghost‑silent flight, it snatches moths and beetles mid‑air in a seamless, predatory dance. It measures a remarkable 12 to 16 inches from beak to tail, the largest of its kind, and its long barred wings and sweeping tail only add to its mystical aura.
Unlike most birds, it doesn’t bother weaving a nest. Instead, it lays a single egg directly on the forest floor, trusting its camouflage and cunning to keep predators at bay. Its call—an eerie, rising whistle after a sharp, clipped note—rings through the night like something out of an old folktale, at once beautiful and unsettling.
Known to science as Lyncornis macrotis, this species is thriving, yet rarely seen, a living relic of wild places and untamed nights. To glimpse one is to feel a sudden jolt of wonder, as if you’ve stumbled into a world where dragons still live, hidden under the cover of leaves.
By day, the nightjar vanishes into the undergrowth, perfectly still, almost impossible to spot even a few feet away. But when twilight falls, it stirs to life, gliding effortlessly through the dark like a phantom. With a wide, gaping mouth and ghost‑silent flight, it snatches moths and beetles mid‑air in a seamless, predatory dance. It measures a remarkable 12 to 16 inches from beak to tail, the largest of its kind, and its long barred wings and sweeping tail only add to its mystical aura.
Unlike most birds, it doesn’t bother weaving a nest. Instead, it lays a single egg directly on the forest floor, trusting its camouflage and cunning to keep predators at bay. Its call—an eerie, rising whistle after a sharp, clipped note—rings through the night like something out of an old folktale, at once beautiful and unsettling.
Known to science as Lyncornis macrotis, this species is thriving, yet rarely seen, a living relic of wild places and untamed nights. To glimpse one is to feel a sudden jolt of wonder, as if you’ve stumbled into a world where dragons still live, hidden under the cover of leaves.
Report
37points
#19
Seahorse couples, such as this pair of thorny seahorses (Hippocampus histrix), greet each other every morning with a unique dance that sometimes involves changing color. The couple promenades and pirouettes together for several minutes before separating for the rest of the day. They greet each other as a way to confirm the other partner is still alive, reinforce their bond, and synchronize their reproductive cycles.
Seahorse couples exhibit one of the most unique and fascinating courtship rituals in the marine world. Their morning dance, often lasting several minutes, involves intricate movements such as promenading and pirouettes, which serve as a form of non-verbal communication. This ritual is not just a display of affection; it plays a critical role in reinforcing their monogamous bond, a rare trait in the animal kingdom. By synchronizing their movements, seahorses ensure mutual recognition and strengthen their partnership, which is essential for their reproductive success.
The color changes observed during these greetings are linked to chromatophores, specialized cells in their skin that expand or contract to display vibrant hues. These visual signals convey information about their health, stress levels, and reproductive readiness. Such precise communication is vital for seahorses, as their survival depends on strong pair bonds and synchronized reproductive efforts. This remarkable behavior highlights the complexity of their social interactions and underscores their unique place in marine biology.
Seahorse couples exhibit one of the most unique and fascinating courtship rituals in the marine world. Their morning dance, often lasting several minutes, involves intricate movements such as promenading and pirouettes, which serve as a form of non-verbal communication. This ritual is not just a display of affection; it plays a critical role in reinforcing their monogamous bond, a rare trait in the animal kingdom. By synchronizing their movements, seahorses ensure mutual recognition and strengthen their partnership, which is essential for their reproductive success.
The color changes observed during these greetings are linked to chromatophores, specialized cells in their skin that expand or contract to display vibrant hues. These visual signals convey information about their health, stress levels, and reproductive readiness. Such precise communication is vital for seahorses, as their survival depends on strong pair bonds and synchronized reproductive efforts. This remarkable behavior highlights the complexity of their social interactions and underscores their unique place in marine biology.
Report
37points
#20
Ants can recognize themselves in mirrors, according to a study that tested three species for self-awareness.
The mirror self-recognition test has been used to assess animal consciousness since the 1970s, when researchers first tested chimpanzees. The method involves placing a colored mark on an animal and observing whether it attempts to remove the mark when seeing its reflection.
Marie-Claire Cammaerts and Roger Cammaerts from the Université libre de Bruxelles tested Myrmica rubra, Myrmica ruginodis, and Myrmica sabuleti by painting blue dots on the clypeus—the facial area near their mouths. When placed in front of mirrors, the marked ants attempted to clean off the blue spots.
The researchers included several control conditions to verify their findings. Ants with brown dots that matched their natural coloring showed no cleaning behavior. Similarly, blue dots placed on the back of their heads, where the ants could not see them, were ignored. The cleaning attempts occurred only when ants could see the blue marks in their reflection.
These findings place ants among the smallest animals to demonstrate self-recognition, a cognitive ability previously documented in great apes, elephants, dolphins, and certain bird species.
The researchers cautiously note that "self recognition is not synonymous of self awareness," but their findings suggest some ants possess cognitive abilities far more sophisticated than previously imagined.
However, these findings face significant scientific scrutiny. Critics have noted the results appear unusually perfect. Additional studies are needed to verify these results before definitively confirming ants' place among self-aware animals.
The mirror self-recognition test has been used to assess animal consciousness since the 1970s, when researchers first tested chimpanzees. The method involves placing a colored mark on an animal and observing whether it attempts to remove the mark when seeing its reflection.
Marie-Claire Cammaerts and Roger Cammaerts from the Université libre de Bruxelles tested Myrmica rubra, Myrmica ruginodis, and Myrmica sabuleti by painting blue dots on the clypeus—the facial area near their mouths. When placed in front of mirrors, the marked ants attempted to clean off the blue spots.
The researchers included several control conditions to verify their findings. Ants with brown dots that matched their natural coloring showed no cleaning behavior. Similarly, blue dots placed on the back of their heads, where the ants could not see them, were ignored. The cleaning attempts occurred only when ants could see the blue marks in their reflection.
These findings place ants among the smallest animals to demonstrate self-recognition, a cognitive ability previously documented in great apes, elephants, dolphins, and certain bird species.
The researchers cautiously note that "self recognition is not synonymous of self awareness," but their findings suggest some ants possess cognitive abilities far more sophisticated than previously imagined.
However, these findings face significant scientific scrutiny. Critics have noted the results appear unusually perfect. Additional studies are needed to verify these results before definitively confirming ants' place among self-aware animals.
Report
35points